Trial Profile
A Randomized, Double-Blind, Placebo-controlled Trial of Antroquinonol in Patients With Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Sep 2019
Price :
$35
*
At a glance
- Drugs Antroquinonol (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Golden Biotechnology Corporation
- 27 Aug 2019 Status changed from recruiting to completed.
- 20 Aug 2018 New trial record